National Institutes of Health (NIH) — 2017 Investments
267 investments dated 2017 · page 2 of 2 · listed companies and verified rows first · show all
BiotechDurham, US
Roarke Horstmeyer(Director)Gregor Horstmeyer(Executive Officer, Director)Mark Harfouche(Executive Officer, Director)Margaret Aery(Executive Officer)Robert Horstmeyer(Director)
BoardPatrick Weiss(Director)
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)Rick Pendergraft(Co-founder & Chief Technology Officer)Dr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Thetis is a clinical-stage pharmaceutical company developing oral TP-317, a first-in-class drug for treating inflammatory bowel disease and solid tumors by activating BLT1 to restore tissue and immune homeostasis.
BiotechMedical DevicesSouthport, US
Gary F Mathias(Manager & Chief Executive Officer)Dennis Willson(Manager)David M Wurzer(Manager)Frank C Sciavolino(Manager)Alan Mendelson(Manager)
Tosk Inc. is a biopharmaceutical company developing small-molecule drugs that reduce the adverse side effects of existing cancer therapies while preserving their efficacy, and that block the activity of cancer genes.
BiotechHealthtechSunnyvale, US
HAROLD CROW(Chairman)BRIAN FRENZEL(President and Chief Executive Officer)CHARLES GARVIN(Director)Brian Frenzel(CEO)
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Sandra Poole(Director)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Lucian Iancovici(Director)Steve White(Executive Officer)
XEME Biopharma is a clinical-stage company developing therapeutic cancer vaccines for active cancer immunotherapy under FDA guidance.
BiotechHealthtechLombard, US
Sunil S. Metkar(Executive Officer)Marius Teodorescu(Director)Anthony Tate(Executive Officer)Richard J. Robb(Executive Officer)Mircea C. Popescu(Executive Officer, Director)Dorel Nasui(Director)
XGenomes develops genomic sequencing technology using fluorescent probes and machine learning to read genetic and epigenetic information at single-molecule resolution.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Kalim Mir(Founder/CEO)in
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inJohn Beck(Executive Officer)Nick Damiano(Executive Officer, Director)
BoardBryan Kim(Director)Robert Weisskoff(Director)Blayne Roeder(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.